Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Kevin Bielamowicz

Concepts (154)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
11
2025
319
1.720
Why?
T-Lymphocytes
8
2025
320
1.090
Why?
Medulloblastoma
4
2022
18
1.080
Why?
Glioma
2
2025
83
1.040
Why?
Glioblastoma
6
2018
101
1.010
Why?
Histiocytosis, Langerhans-Cell
2
2024
34
1.000
Why?
Central Nervous System Neoplasms
2
2025
69
0.990
Why?
Proto-Oncogene Proteins c-met
1
2025
23
0.910
Why?
Neoplasm Recurrence, Local
4
2025
647
0.860
Why?
RNA-Binding Protein EWS
1
2024
14
0.830
Why?
Neoplasms, Germ Cell and Embryonal
1
2024
21
0.820
Why?
Interleukin-13 Receptor alpha2 Subunit
3
2018
4
0.810
Why?
Protein Kinase Inhibitors
1
2025
234
0.790
Why?
Drug Resistance, Neoplasm
1
2025
350
0.760
Why?
Craniospinal Irradiation
2
2021
9
0.750
Why?
Receptor, erbB-2
4
2025
79
0.730
Why?
Receptors, Antigen, T-Cell
4
2018
52
0.720
Why?
Hypothyroidism
2
2021
58
0.700
Why?
Protons
2
2021
75
0.590
Why?
Antigenic Variation
2
2018
3
0.580
Why?
Receptor, EphA2
1
2018
6
0.550
Why?
Immunotherapy, Adoptive
4
2025
163
0.400
Why?
Cerebellar Neoplasms
3
2022
24
0.400
Why?
Neoplasms
4
2025
1335
0.390
Why?
Child, Preschool
9
2025
4164
0.390
Why?
Neuroblastoma
2
2024
55
0.380
Why?
Humans
29
2025
53246
0.340
Why?
Cancer Vaccines
3
2021
79
0.340
Why?
Child
15
2025
7384
0.330
Why?
Testicular Hydrocele
1
2010
3
0.320
Why?
Thrombocytopenia
1
2011
89
0.320
Why?
Genital Diseases, Female
1
2010
18
0.320
Why?
Hernia, Inguinal
1
2010
22
0.320
Why?
Vagina
1
2010
45
0.310
Why?
Immunotherapy
4
2024
266
0.280
Why?
Infant
4
2025
3808
0.270
Why?
Female
14
2025
28792
0.250
Why?
Male
12
2025
27444
0.250
Why?
Antineoplastic Agents
3
2024
1232
0.250
Why?
para-Aminobenzoates
1
2025
1
0.230
Why?
Lactams, Macrocyclic
1
2025
19
0.230
Why?
Lactams
1
2025
28
0.230
Why?
Aminopyridines
1
2025
19
0.230
Why?
Pathology, Molecular
1
2025
28
0.230
Why?
Pathology, Surgical
1
2025
23
0.220
Why?
Neurofibroma, Plexiform
1
2024
5
0.220
Why?
Sulfonamides
1
2025
139
0.210
Why?
Benzamides
1
2024
52
0.210
Why?
Molecular Targeted Therapy
1
2025
138
0.210
Why?
Pyrazoles
1
2025
123
0.210
Why?
Neurofibromatosis 1
1
2024
36
0.210
Why?
Rhabdoid Tumor
1
2024
13
0.210
Why?
Neoplastic Syndromes, Hereditary
1
2024
18
0.200
Why?
Eyelid Diseases
1
2024
11
0.200
Why?
Xenograft Model Antitumor Assays
3
2020
228
0.200
Why?
Gene Rearrangement
1
2024
76
0.200
Why?
Tumor Cells, Cultured
3
2020
441
0.200
Why?
Bacterial Infections
1
2023
96
0.190
Why?
Bacteremia
1
2023
87
0.190
Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2025
1043
0.180
Why?
Sarcoma, Ewing
1
2022
32
0.180
Why?
Proton Therapy
1
2021
12
0.170
Why?
Hematologic Neoplasms
1
2023
101
0.170
Why?
Adrenal Insufficiency
1
2021
19
0.170
Why?
DNA-Binding Proteins
1
2024
423
0.170
Why?
Leukemia
1
2021
67
0.170
Why?
Mice, SCID
2
2018
180
0.160
Why?
Sepsis
1
2023
240
0.160
Why?
Hypothalamic Diseases
1
2020
1
0.160
Why?
Ependymoma
1
2020
7
0.160
Why?
Cerebrospinal Fluid
1
2020
29
0.160
Why?
Adolescent
5
2025
6912
0.150
Why?
Methylphenidate
1
2020
76
0.150
Why?
Mice
5
2025
5982
0.140
Why?
Mice, Inbred NOD
1
2018
90
0.130
Why?
Weight Loss
1
2020
257
0.130
Why?
Central Nervous System Stimulants
1
2020
201
0.130
Why?
Cell Proliferation
2
2018
1031
0.130
Why?
Receptors, Cell Surface
1
2017
109
0.130
Why?
Diagnosis, Differential
3
2024
1038
0.120
Why?
Tumor Escape
1
2016
18
0.120
Why?
Apoptosis
2
2018
1139
0.120
Why?
Neoplasm Proteins
1
2017
330
0.110
Why?
Animals
5
2025
13528
0.100
Why?
Cell Nucleus
1
2014
187
0.100
Why?
Retrospective Studies
3
2021
6821
0.100
Why?
Up-Regulation
1
2014
456
0.090
Why?
Plasma Cell Granuloma, Pulmonary
1
2011
1
0.090
Why?
Septo-Optic Dysplasia
1
2011
3
0.090
Why?
Moyamoya Disease
1
2011
7
0.090
Why?
Obesity
1
2020
1205
0.090
Why?
Slipped Capital Femoral Epiphyses
1
2011
9
0.090
Why?
Lung Neoplasms
1
2017
645
0.090
Why?
Medical History Taking
1
2011
47
0.080
Why?
Tumor Microenvironment
2
2024
274
0.080
Why?
Lymphocyte Activation
2
2025
163
0.080
Why?
Young Adult
3
2025
4514
0.080
Why?
Adult
5
2025
14541
0.080
Why?
Ultrasonography
1
2010
426
0.070
Why?
Antigens, Neoplasm
2
2021
146
0.070
Why?
Prognosis
3
2020
2118
0.070
Why?
Cell Line, Tumor
2
2025
1470
0.060
Why?
Pyrrolidines
1
2025
65
0.060
Why?
Programmed Cell Death 1 Receptor
1
2025
46
0.050
Why?
MutS Homolog 2 Protein
1
2024
12
0.050
Why?
DNA Mismatch Repair
1
2024
18
0.050
Why?
CTLA-4 Antigen
1
2024
32
0.050
Why?
Follow-Up Studies
2
2020
2318
0.050
Why?
Survival Rate
2
2017
949
0.050
Why?
Fever
1
2023
112
0.050
Why?
Maximum Tolerated Dose
1
2022
42
0.050
Why?
Biopsy
1
2024
600
0.040
Why?
Glucocorticoids
1
2024
236
0.040
Why?
Longitudinal Studies
1
2024
774
0.040
Why?
Growth Hormone
1
2021
98
0.040
Why?
Radiotherapy Dosage
1
2021
249
0.040
Why?
Incidence
1
2024
1085
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
238
0.040
Why?
Injections, Intraventricular
1
2020
12
0.040
Why?
Colorectal Neoplasms
1
2024
302
0.040
Why?
HEK293 Cells
1
2020
235
0.040
Why?
Neoplasm Metastasis
1
2020
237
0.040
Why?
Cross-Sectional Studies
1
2024
1723
0.040
Why?
Quality of Life
1
2024
902
0.040
Why?
Drug Delivery Systems
1
2020
148
0.030
Why?
Treatment Outcome
2
2020
5597
0.030
Why?
Mutation
1
2024
1338
0.030
Why?
Microfilament Proteins
1
2017
44
0.030
Why?
Prospective Studies
1
2023
2412
0.030
Why?
Anti-Bacterial Agents
1
2023
832
0.030
Why?
Magnetic Resonance Imaging
1
2024
1587
0.030
Why?
Aged
2
2024
10430
0.030
Why?
Adenoviridae
1
2017
46
0.030
Why?
Herpesvirus 4, Human
1
2017
44
0.030
Why?
Cytomegalovirus
1
2017
42
0.030
Why?
Interleukin-13
1
2016
15
0.030
Why?
Neoplasm Transplantation
1
2016
86
0.030
Why?
Infant, Newborn
1
2024
2913
0.030
Why?
Transgenes
1
2016
55
0.030
Why?
Protein Multimerization
1
2016
57
0.030
Why?
Middle Aged
2
2024
13422
0.030
Why?
Protein Binding
1
2016
670
0.030
Why?
Case-Control Studies
1
2017
1212
0.030
Why?
Adoptive Transfer
1
2014
29
0.030
Why?
Cell Cycle
1
2014
237
0.020
Why?
Recurrence
1
2014
694
0.020
Why?
Groin
1
2011
16
0.020
Why?
Cough
1
2011
58
0.020
Why?
Hypoglycemia
1
2011
62
0.020
Why?
Penis
1
2011
85
0.020
Why?
Anemia, Sickle Cell
1
2011
105
0.020
Why?
Radiography
1
2011
476
0.020
Why?
Pain
1
2011
353
0.020
Why?
Bielamowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description